To further assess whether these results could be actually due to the reported differences in BMI, ALT, and AST between the two groups (NAFL and NASH), a linear regression analysis was performed by two models using NAS or, alternatively, fibrosis as independent variables. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.